{"id":38457,"date":"2026-03-25T11:11:06","date_gmt":"2026-03-25T11:11:06","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/38457\/"},"modified":"2026-03-25T11:11:06","modified_gmt":"2026-03-25T11:11:06","slug":"merck-to-buy-terns-for-6-7b-taking-a-leukemia-drug-that-could-challenge-novartis-scemblix","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/38457\/","title":{"rendered":"Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis\u2019 Scemblix"},"content":{"rendered":"<p>Mer\u00adck is look\u00ading to fur\u00adther so\u00adlid\u00adi\u00adfy its on\u00adcol\u00ado\u00adgy pipeline via a $6.7 bil\u00adlion cash ac\u00adqui\u00adsi\u00adtion of Terns Phar\u00adma\u00adceu\u00adti\u00adcals and its in\u00adves\u00adti\u00adga\u00adtion\u00adal treat\u00adment for chron\u00adic myeloid \u2026<\/p>\n<p>    <img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/endpoints.news\/wp-content\/themes\/endpoints-rakia\/assets\/svg\/epn_logo.svg\" alt=\"Endpoints News\"\/><br \/>\n    Sign up to read this article for free.<\/p>\n<p>Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.<\/p>\n","protected":false},"excerpt":{"rendered":"Mer\u00adck is look\u00ading to fur\u00adther so\u00adlid\u00adi\u00adfy its on\u00adcol\u00ado\u00adgy pipeline via a $6.7 bil\u00adlion cash ac\u00adqui\u00adsi\u00adtion of Terns Phar\u00adma\u00adceu\u00adti\u00adcals&hellip;\n","protected":false},"author":2,"featured_media":38458,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[127],"tags":[22443,18506,3772,22438,22442,206,22444,2536,22441,22440,22439],"class_list":{"0":"post-38457","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-novartis","8":"tag-amy-burroughs","9":"tag-chronic-myeloid-leukemia","10":"tag-deals","11":"tag-keytruda","12":"tag-merck-acquisition","13":"tag-novartis","14":"tag-novartis-scemblix","15":"tag-pharma","16":"tag-pharmaceutical-ma","17":"tag-tern-701","18":"tag-terns-pharmaceuticals"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116289515531850933","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/38457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=38457"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/38457\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/38458"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=38457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=38457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=38457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}